The interaction between CD8+ cytotoxic T‐lymphocyte cells and the ECM to identify mechanisms that might relate to tumor progression and shortened survival has been studied mainly in small and heterogeneous series and the data are inconclusive.12, 13, 14, 15. The gene discussed is CD8A; the disease is neoplasm.